Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Cash from Investing Activities Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -114.28%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 826.39%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -674.01%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -166.24%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -122.45%
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn -1,289.66%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1,289.66%
Dec 31, 2025 87.89%
Sep 30, 2025 -4,753.10%
Jun 30, 2025 1.99%
Mar 31, 2025 93.26%
Dec 31, 2024 -475.26%
Sep 30, 2024 117.41%
Jun 30, 2024 -160.06%
Mar 31, 2024 -789.81%
Dec 31, 2023 71.85%
Sep 30, 2023 -73.53%
Jun 30, 2023 18.88%
Mar 31, 2023 -357.43%
Dec 31, 2022 -444.27%
Sep 30, 2022 35.52%
Jun 30, 2022 -1.66%
Mar 31, 2022 92.88%
Dec 31, 2021 86.19%
Sep 30, 2021 18.31%
Jun 30, 2021 13.17%
Mar 31, 2021 -91.44%
Dec 31, 2020 -186.63%
Sep 30, 2020 -134.47%
Jun 30, 2020 -47.27%
Mar 31, 2020 -150.81%
Dec 31, 2019 33.14%
Sep 30, 2019 183.98%
Jun 30, 2019 86.66%
Mar 31, 2019 86.06%
Dec 31, 2018 5.50%
Sep 30, 2018 -75.97%
Jun 30, 2018 -39.07%
Mar 31, 2018 -220.64%
Dec 31, 2017 -1.95%
Sep 30, 2017 19.61%
Jun 30, 2017 -410.47%
Mar 31, 2017 89.56%
Dec 31, 2016 -177.32%
Sep 30, 2016 -56.92%
Jun 30, 2016 589.74%
Mar 31, 2016 -786.07%
Dec 31, 2015 116.17%
Sep 30, 2015 -26.58%
Jun 30, 2015 85.38%
Mar 31, 2015 -65.30%
Dec 31, 2014 -1,904.98%
Sep 30, 2014 23.38%
Jun 30, 2014 39.49%
Mar 31, 2014 -762.19%
Dec 31, 2013 -108.83%
Sep 30, 2013 -597.42%
Jun 30, 2013 -589.65%
Mar 31, 2013 -57.14%
Dec 31, 2012 -229.33%
Sep 30, 2012 40.48%
Jun 30, 2012 -5.62%
Mar 31, 2012 89.08%